Bristol John W & CO Inc Novartis Ag Transaction History
Bristol John W & CO Inc
- $5.85 Billion
- Q3 2025
A detailed history of Bristol John W & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Bristol John W & CO Inc holds 581,723 shares of NVS stock, worth $76.5 Million. This represents 1.27% of its overall portfolio holdings.
Number of Shares
581,723
Previous 592,281
1.78%
Holding current value
$76.5 Million
Previous $71.7 Million
4.09%
% of portfolio
1.27%
Previous 1.25%
Shares
37 transactions
Others Institutions Holding NVS
# of Institutions
1,605Shares Held
137MCall Options Held
1.55MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...